Vertex Pharmaceuticals (VRTX) EPS (Basic) (2009 - 2026)
Vertex Pharmaceuticals (VRTX) recorded quarterly EPS (Basic) of $4.06 in Q1 2026, down 13.43% quarter-over-quarter from $4.69 in Q4 2025, and up 61.11% on a YoY basis from $2.52 in Q1 2025.
Vertex Pharmaceuticals (VRTX) EPS (Basic) (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals' EPS (Basic) history runs 18 years deep, the most recent figure standing at $4.06 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 61.11% year-over-year to $4.06; the TTM figure through Mar 2026 stood at $17.01 (up 545.29% YoY), while the FY2025 annual figure was $15.46, up 843.27% from the prior year.
- EPS (Basic) was $4.06 for Q1 2026 at Vertex Pharmaceuticals, down from $4.69 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $4.69 in Q4 2025 to a low of -$13.92 in Q2 2024.
- Historically, EPS (Basic) has averaged $2.62 across 5 years, with a median of $3.63 in 2022.
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) surged 1119.23% in 2022, then slumped 492.11% in 2024.
- A 5-year view of EPS (Basic) shows it stood at $3.19 in 2022, then climbed by 17.87% to $3.76 in 2023, then dropped by 6.12% to $3.53 in 2024, then surged by 32.86% to $4.69 in 2025, then retreated by 13.43% to $4.06 in 2026.
- The last three EPS (Basic) figures came in at $4.06 (Q1 2026), $4.69 (Q4 2025), and $4.24 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 6.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.06 |
| Dec 31, 2025 | 4.69 |
| Sep 30, 2025 | 4.24 |
| Jun 30, 2025 | 4.02 |
| Mar 31, 2025 | 2.52 |
| Dec 31, 2024 | 3.53 |
| Sep 30, 2024 | 4.05 |
| Jun 30, 2024 | -13.92 |
| Mar 31, 2024 | 4.26 |
| Dec 31, 2023 | 3.76 |
| Sep 30, 2023 | 4.01 |
| Jun 30, 2023 | 3.55 |
| Mar 31, 2023 | 2.72 |
| Dec 31, 2022 | 3.19 |
| Sep 30, 2022 | 3.63 |
| Jun 30, 2022 | 3.17 |
| Mar 31, 2022 | 2.99 |
| Dec 31, 2021 | 3.01 |
| Sep 30, 2021 | 3.30 |
| Jun 30, 2021 | 0.26 |